4/A: 3M Senior Vice President Theresa E. Reinseth Reports Changes in Beneficial Ownership After Solventum Spin-off
SEC Form 4/A
Theresa E. Reinseth, Senior Vice President/CAO of 3M, filed an amended Form 4 detailing changes in her beneficial ownership of 3M stock following the spin-off of Solventum on April 1, 2024.
Summary
- Theresa E. Reinseth, a Senior Vice President/CAO at 3M, filed an amended Form 4 with the SEC.
- The filing reports changes in her beneficial ownership of 3M securities.
- The changes are related to restricted stock units and reflect adjustments due to the spin-off of Solventum, 3M's healthcare business, on April 1, 2024.
- On April 1, 2024, 5,749 restricted stock units were acquired.
- These units were granted on July 1, 2022, and their performance criteria were met as of April 1, 2024.
- The restricted stock units will vest on June 30, 2024, contingent upon continued service with 3M.
- Following the reported transaction, Reinseth directly owns 5,749 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to executive stock ownership, indicating a neutral sentiment.
Future Outlook
The restricted stock units will vest on June 30, 2024, presuming continued service with 3M through such date.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies like 3M. The Solventum spin-off is a strategic move by 3M to focus on its core businesses.
Comparison to Industry Standards
- Executive compensation packages including restricted stock units are a standard practice among large, publicly traded companies such as 3M.
- Companies like General Electric (GE), Honeywell (HON), and Siemens (SIE) also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and performance criteria associated with these units are typically benchmarked against industry peers to ensure competitiveness and effectiveness in incentivizing performance.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and alignment of interests.
- Employees holding similar stock units may be interested in the vesting schedule and performance criteria.
Key Dates
| Date | Description |
|---|---|
| 07/01/2022 | Restricted stock units granted to the reporting person |
| 04/01/2024 | Date of earliest transaction and Solventum spin-off |
| 05/08/2024 | Date of original filing |
| 05/14/2024 | Date of signature on the amended form |
| 06/30/2024 | Vesting date for the restricted stock units |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.